Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Wave Life Sciences Ltd.

Report trial results for PRECISION-HD1 and PRECISION-HD2

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
11 Jan 2021
Due
31 Mar 2021
Delivered
29 Mar 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Trial results expected by end of 1Q 2021”

What we found

Evidence strength A What the grades mean

The company announced the results of the PRECISION-HD2 and PRECISION-HD1 trials on March 29, 2021, which was within the first quarter of 2021.

  • A
    Wave Life Sciences Ltd. 10-Q filed 2021-05-13 Regulatory filing · published 13 May 2021 · retrieved 24 Oct 2026 · kept permanently by the SEC · fingerprint 92a7a8ad4d6b
    “On March 29, 2021, we announced our decision to discontinue clinical development of WVE-120102 and WVE-120101... The decision to discontinue WVE-120102 was based on the results of the 15 PRECISION-HD2 clinical trials” ✓ confirmed on the page
  • A
    Wave Life Sciences Ltd. 10-Q filed 2021-05-13 Regulatory filing · published 13 May 2021 · retrieved 24 Oct 2026 · kept permanently by the SEC · fingerprint 92a7a8ad4d6b
    “Results of the PRECISION-HD1 core trial in all participants through 16 mg were similar to those in the PRECISION-HD2 trial at the equivalent dose levels.” ✓ confirmed on the page

Market reaction: the shares moved -1.2% against the S&P 500 over the three sessions around the disclosure (12 May 2021 to 17 May 2021). What this measures

Checked 24 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Deliverable
PRECISION-HD1 and PRECISION-HD2 trial results
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and reads it as “no_evidence”.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Wave Life Sciences Ltd.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-WVE-021627 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.